.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Farmers Insurance
Chubb
US Army
Teva
Chinese Patent Office
Argus Health
Medtronic
Julphar
Healthtrust

Generated: June 28, 2017

DrugPatentWatch Database Preview

DICLOFENAC SODIUM AND MISOPROSTOL Drug Profile

« Back to Dashboard

What is the patent landscape for Diclofenac Sodium And Misoprostol, and what generic Diclofenac Sodium And Misoprostol alternatives are available?

Diclofenac Sodium And Misoprostol is a drug marketed by Exela Holdings, Sandoz, Actavis Labs Fl Inc, and Amneal Pharms. and is included in four NDAs.

The generic ingredient in DICLOFENAC SODIUM AND MISOPROSTOL is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.

Summary for Tradename: DICLOFENAC SODIUM AND MISOPROSTOL

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list11
Clinical Trials: see list104,526
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DICLOFENAC SODIUM AND MISOPROSTOL at DailyMed

Pharmacology for Tradename: DICLOFENAC SODIUM AND MISOPROSTOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Holdings
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL200540-001Mar 14, 2014ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL203995-001Nov 25, 2016ABRXNoNo► Subscribe► Subscribe
Sandoz
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL200158-002May 9, 2013ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL203995-002Nov 25, 2016ABRXNoNo► Subscribe► Subscribe
Exela Holdings
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL200540-002Mar 14, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Dow
Chubb
Fish and Richardson
AstraZeneca
Queensland Health
Mallinckrodt
Medtronic
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot